Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays
Go back to Lilly's Strong GLP-1 Results Signal Robust Market Growth for Novo Nordisk says Barclays| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 +3.51 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.11 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 3,014,683 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.88 +2.69 (6.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $44.01 | 52 Week Low | $32.80 | |||
| Day High | $46.45 | P/E | N/A | |||
| Day Low | $43.90 | EPS | $0.00 | |||
| Volume | 17,128,975 | |||||
